These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3318843)

  • 1. The cytochromes P-448--a unique family of enzymes involved in chemical toxicity and carcinogenesis.
    Ioannides C; Parke DV
    Biochem Pharmacol; 1987 Dec; 36(24):4197-207. PubMed ID: 3318843
    [No Abstract]   [Full Text] [Related]  

  • 2. Do cytochromes P-448 and P-450 have different functions?
    Paolini M; Bauer C; Biagi GL; Cantelli-Forti G
    Biochem Pharmacol; 1989 Jul; 38(14):2223-5. PubMed ID: 2665747
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of mixed-function oxidases in the formation of biological reactive intermediates.
    Parke DV; Ioannides C
    Adv Exp Med Biol; 1981; 136 Pt A():23-38. PubMed ID: 7344459
    [No Abstract]   [Full Text] [Related]  

  • 4. Active metabolites in toxicology: the role of cytochrome P-448 and flavoprotein oxidases.
    Parke DV; Ioannides C
    Arch Toxicol Suppl; 1984; 7():183-92. PubMed ID: 6595982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochromes P-450 and the activation and inactivation of mutagens and carcinogens.
    Strobel HW; Fang WF; Takazawa RS; Stralka DJ; Newaz SN; Kurzban GP; Nelson DR; Beyer RS
    Basic Life Sci; 1986; 39():61-71. PubMed ID: 3094496
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of the mutagenic activation of N-nitrosopropylamines by various animal species and man: evidence for a cytochrome P-450 dependent reaction.
    Yamazaki H; Mori Y; Toyoshi K; Nagai H; Koda A; Konishi Y
    Jpn J Cancer Res; 1986 Feb; 77(2):107-17. PubMed ID: 3082822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of drug-metabolizing enzymes.
    Parke DV
    Biochem Soc Trans; 1983 Aug; 11(4):457-8. PubMed ID: 6617976
    [No Abstract]   [Full Text] [Related]  

  • 8. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
    Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4--implications for susceptibility to Parkinson's disease.
    Coleman T; Ellis SW; Martin IJ; Lennard MS; Tucker GT
    J Pharmacol Exp Ther; 1996 May; 277(2):685-90. PubMed ID: 8627546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cytochromes P450 in metabolism of carcinogenic aristolochic acid I: evidence of their contribution to aristolochic acid I detoxication and activation in rat liver.
    Stiborova M; Mares J; Levova K; Pavlickova J; Barta F; Hodek P; Frei E; Schmeiser HH
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():121-30. PubMed ID: 22167220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activation of carcinogens and toxic chemicals.
    Parke DV; Ioannides C; Lewis DF
    Hum Toxicol; 1988 Sep; 7(5):397-404. PubMed ID: 3192223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytochromes P450 and mechanisms of chemical carcinogenesis.
    Parke DV
    Environ Health Perspect; 1994 Oct; 102(10):852-3. PubMed ID: 9644192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochromes in psychopharmacology.
    von Moltke LL; Greenblatt DJ; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 1994 Feb; 14(1):1-4. PubMed ID: 8150999
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytochrome P-450 monooxygenases and interactions of psychotropic drugs.
    Shen WW; Lin KM
    Int J Psychiatry Med; 1991; 21(1):47-56. PubMed ID: 2066257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytochrome p450 enzymes of importance for the bioactivation of methyleugenol to the proximate carcinogen 1'-hydroxymethyleugenol.
    Jeurissen SM; Bogaards JJ; Boersma MG; ter Horst JP; Awad HM; Fiamegos YC; van Beek TA; Alink GM; Sudhölter EJ; Cnubben NH; Rietjens IM
    Chem Res Toxicol; 2006 Jan; 19(1):111-6. PubMed ID: 16411663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsomal metabolism of 2-acetylaminofluorene, role in mutagenicity and carcinogenicity.
    Roberfroid M; Razzouk C; Agazzi-Léonard E; Batardy-Grégoire M; Poncelet F; Mercier M
    Adv Exp Med Biol; 1981; 136 Pt B():921-9. PubMed ID: 7344520
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of cytochrome P4501 as an indicator of potential chemical carcinogenesis.
    Ioannides C; Parke DV
    Drug Metab Rev; 1993; 25(4):485-501. PubMed ID: 8313839
    [No Abstract]   [Full Text] [Related]  

  • 19. Inverse correlation between species life span and specific cytochrome P-448 content of cultured fibroblasts.
    Pashko LL; Schwartz AG
    J Gerontol; 1982 Jan; 37(1):38-41. PubMed ID: 7053396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactivation of N-nitrosopiperidine to mutagens: role of hepatic cytochrome P-450 proteins and contribution of cytosolic fraction.
    Ayrton AD; Smith JN; Ioannides C
    Carcinogenesis; 1987 Nov; 8(11):1691-5. PubMed ID: 3664960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.